scispace - formally typeset
Open AccessJournal ArticleDOI

Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects

Reads0
Chats0
TLDR
Brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.
Abstract
Although structural brain alterations in schizophrenia have been demonstrated extensively, their quantitative distribution has not been studied over the last 14 years despite advances in neuroimaging. Moreover, a volumetric meta-analysis has not been conducted in antipsychotic-naive patients. Therefore, meta-analysis on cross-sectional volumetric brain alterations in both medicated and antipsychotic-naive patients was conducted. Three hundred seventeen studies published from September 1, 1998 to January 1, 2012 comprising over 9000 patients were selected for meta-analysis, including 33 studies in antipsychotic-naive patients. In addition to effect sizes, potential modifying factors such as duration of illness, sex composition, current antipsychotic dose, and intelligence quotient matching status of participants were extracted where available. In the sample of medicated schizophrenia patients (n = 8327), intracranial and total brain volume was significantly decreased by 2.0% (effect size d = -0.17) and 2.6% (d = -0.30), respectively. Largest effect sizes were observed for gray matter structures, with effect sizes ranging from -0.22 to -0.58. In the sample of antipsychotic-naive patients (n = 771), volume reductions in caudate nucleus (d = -0.38) and thalamus (d = -0.68) were more pronounced than in medicated patients. White matter volume was decreased to a similar extent in both groups, while gray matter loss was less extensive in antipsychotic-naive patients. Gray matter reduction was associated with longer duration of illness and higher dose of antipsychotic medication at time of scanning. Therefore, brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

T.G.M. van Erp, +66 more
- 01 Apr 2016 - 
TL;DR: Worldwide cooperative analyses of brain imaging data support a profile of subcortical abnormalities in schizophrenia, which is consistent with that based on traditional meta-analytic approaches, and validates that collaborative data analyses can readily be used across brain phenotypes and disorders.
Journal ArticleDOI

Mind-wandering as spontaneous thought: a dynamic framework

TL;DR: It is proposed that mind-wandering is best understood as a member of a family of spontaneous-thought phenomena that also includes creative thought and dreaming, and can shed new light on mental disorders that are marked by alterations in spontaneous thought, including depression, anxiety and attention deficit hyperactivity disorder.
Journal ArticleDOI

Genome-wide association studies of brain imaging phenotypes in UK Biobank

TL;DR: Genome-wide association studies of brain imaging data from 8,428 individuals in UK Biobank show that many of the 3,144 traits studied are heritable, and genes associated with individual phenotypes are identified.
Journal ArticleDOI

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies

TL;DR: Schizophrenia is characterized by progressive gray matter volume decreases and lateral ventricular volume increases, and some of these neuroanatomical alterations may be associated with antipsychotic treatment.
References
More filters
Journal ArticleDOI

A systematic review of the effects of antipsychotic drugs on brain volume.

TL;DR: Some evidence points towards the possibility that antipsychotic drugs reduce the volume of brain matter and increase ventricular or fluid volume, as well as some of the abnormalities usually attributed to schizophrenia.
Journal ArticleDOI

Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients.

TL;DR: First-episode schizophrenia patients who use cannabis show a more pronounced brain volume reduction over a 5-year follow-up than patients with schizophrenia who do not use cannabis, which may help explain some of the detrimental effects of cannabis use in schizophrenia.
Journal ArticleDOI

Meta-analysis of brain and cranial size in schizophrenia

TL;DR: Evidence for a small, but statistically significant reduction in brain and intracranial size in schizophrenia is found, but no evidence for a reduction in extracranialsize is found.
Journal ArticleDOI

Intracranial volume change in childhood.

TL;DR: Three main periods can be distinguished, each lasting approximately 5 years (0-5, 5-10, and 10-15 years), during which the growth of intracranial volume is linear.
Related Papers (5)

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

T.G.M. van Erp, +66 more
- 01 Apr 2016 - 

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke, +354 more
- 24 Jul 2014 -